Participants 165 225 5
Cooperative Group of Study and Treatment of Multiple Myeloma
Participants 948 983 3
responsive patients were randomised
Participants 1196 1248 3
patients originally treated with MPH-P for induction
Participants 1351 1402 3
206 stage I, II and III patients treated with MPH-P
Participants 1416 1437 3
75 stage III patients
